Workflow
摩托车及其他
icon
Search documents
摩托车及其他板块12月18日跌0.58%,千里科技领跌,主力资金净流入1576.15万元
以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。 证券之星消息,12月18日摩托车及其他板块较上一交易日下跌0.58%,千里科技领跌。当日上证指数报 收于3876.37,上涨0.16%。深证成指报收于13053.98,下跌1.29%。摩托车及其他板块个股涨跌见下 表: 从资金流向上来看,当日摩托车及其他板块主力资金净流入1576.15万元,游资资金净流出332.04万元, 散户资金净流出1244.11万元。摩托车及其他板块个股资金流向见下表: ...
摩托车及其他板块12月17日涨1.35%,征和工业领涨,主力资金净流出2823.42万元
证券之星消息,12月17日摩托车及其他板块较上一交易日上涨1.35%,征和工业领涨。当日上证指数报 收于3870.28,上涨1.19%。深证成指报收于13224.51,上涨2.4%。摩托车及其他板块个股涨跌见下表: 从资金流向上来看,当日摩托车及其他板块主力资金净流出2823.42万元,游资资金净流出1806.83万 元,散户资金净流入4630.25万元。摩托车及其他板块个股资金流向见下表: 以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。 ...
摩托车及其他板块12月16日跌0.28%,征和工业领跌,主力资金净流出8739.57万元
证券之星消息,12月16日摩托车及其他板块较上一交易日下跌0.28%,征和工业领跌。当日上证指数报 收于3824.81,下跌1.11%。深证成指报收于12914.67,下跌1.51%。摩托车及其他板块个股涨跌见下 表: 以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。 从资金流向上来看,当日摩托车及其他板块主力资金净流出8739.57万元,游资资金净流出4169.85万 元,散户资金净流入1.29亿元。摩托车及其他板块个股资金流向见下表: ...
摩托车及其他板块12月15日跌1.63%,征和工业领跌,主力资金净流出1.58亿元
证券之星消息,12月15日摩托车及其他板块较上一交易日下跌1.63%,征和工业领跌。当日上证指数报 收于3867.92,下跌0.55%。深证成指报收于13112.09,下跌1.1%。摩托车及其他板块个股涨跌见下表: 以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。 从资金流向上来看,当日摩托车及其他板块主力资金净流出1.58亿元,游资资金净流入7246.01万元,散 户资金净流入8564.49万元。摩托车及其他板块个股资金流向见下表: ...
摩托车及其他板块12月10日涨2.1%,信隆健康领涨,主力资金净流出5448.51万元
证券之星消息,12月10日摩托车及其他板块较上一交易日上涨2.1%,信隆健康领涨。当日上证指数报 收于3900.5,下跌0.23%。深证成指报收于13316.42,上涨0.29%。摩托车及其他板块个股涨跌见下表: 从资金流向上来看,当日摩托车及其他板块主力资金净流出5448.51万元,游资资金净流入3848.73万 元,散户资金净流入1599.78万元。摩托车及其他板块个股资金流向见下表: 以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。 ...
摩托车及其他板块12月9日涨0.4%,信隆健康领涨,主力资金净流入1.38亿元
证券之星消息,12月9日摩托车及其他板块较上一交易日上涨0.4%,信隆健康领涨。当日上证指数报收 于3909.52,下跌0.37%。深证成指报收于13277.36,下跌0.39%。摩托车及其他板块个股涨跌见下表: 以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。 从资金流向上来看,当日摩托车及其他板块主力资金净流入1.38亿元,游资资金净流出3845.73万元,散 户资金净流出9968.81万元。摩托车及其他板块个股资金流向见下表: ...
12月3日晚间重要公告一览
Xi Niu Cai Jing· 2025-12-03 10:19
Group 1 - Dongfang Electric announced that three executives plan to reduce their holdings by a total of no more than 30,000 shares due to personal financial needs [1] - Yahu Pharmaceutical's APL-1401 clinical trial data was presented at the 19th European Colorectal Congress, indicating progress in treating moderate to severe ulcerative colitis [1] - Guizhou Bai Ling's actual controller is under investigation by the China Securities Regulatory Commission for insider trading and information disclosure violations [3] Group 2 - Bairen Medical's ePTFE pericardial membrane product has been approved for registration, ending the reliance on imports for this product in the domestic market [4] - Qianxin received approval for a total of 2 billion yuan in technology innovation bonds, with plans to issue medium-term notes and short-term financing bonds [6] - Tengjing Technology's shareholder plans to reduce holdings by no more than 1.96% of the company's shares [7] Group 3 - Yuntianhua's subsidiary is required to pay 386 million yuan in overdue taxes and penalties, which will impact the company's net profit for 2025 [8] - Jianyou Pharmaceutical's propofol emulsion injection has received FDA approval in the United States [9] - Suzhou Gaoxin successfully acquired land use rights for a residential project for 360 million yuan [9] Group 4 - Chalco International's subsidiary won a bid for a 3.03 billion yuan electrolytic aluminum project [11] - Tai Long Pharmaceutical's stock will continue to be suspended due to potential changes in control as the major shareholder is planning a share transfer [12] - Qianli Technology reported a 63.44% year-on-year increase in automobile sales for November, although new energy vehicle sales decreased by 43.98% [13] Group 5 - Fosun Pharma's innovative drug FXS0887 has received approval for a Phase I clinical trial for advanced malignant solid tumors [14] - Guoen Co. has obtained approval for a project to produce 20,000 square meters of aviation-grade acrylic glass, with a total investment of 560 million yuan [15] - Guofa Co.'s chairman resigned due to personal reasons [17] Group 6 - Shanghai Construction won a bid for a state-owned construction land use right for 264 million yuan [18] - Weixin Kang's subsidiary received approval for a clinical trial of lidocaine cream for local anesthesia [20] - Sanxing Medical's subsidiary is a candidate for a 152 million yuan transformer procurement project for the State Grid [20] Group 7 - People's Daily announced the resignation of its president due to work changes, while retaining other leadership roles [21] - Beibu Gulf Port reported a 0.29% year-on-year increase in cargo throughput for November [22] - Chongqing Construction won three engineering projects with a total value of approximately 2.773 billion yuan [23] Group 8 - Xingyu Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange [24] - Huajian Group signed a design contract worth 160 million yuan for a comprehensive project [25] - Wankai New Materials plans to invest 350 million yuan in a technical transformation project for producing 100,000 tons of adipic acid [26] Group 9 - Kaipuyun received a government subsidy of 18 million yuan, which is 87.43% of its net profit for the last audited fiscal year [28] - Ningbo Port expects a 10.8% year-on-year increase in container throughput for November [30] - An Cai High-Tech plans to invest 498 million yuan to upgrade its photovoltaic glass production line [32] Group 10 - Shunhao Co. stated that its existing business has not generated synergies with the rail business, which faces various risks [34] - Yihualu plans to publicly transfer 35% of its stake in Liaoyun Company [35] - ST Wanfang's shareholder plans to reduce holdings by no more than 3% of the company's shares [36] Group 11 - Youyou Food's shareholder plans to reduce holdings by no more than 110,000 shares [38] - Hengtong Optic-Electric's incentive fund has spent 49.98 million yuan to purchase company shares [41] - Zoli Pharmaceutical plans to issue convertible bonds to raise no more than 1.556 billion yuan for various projects [42]
广汽集团等238股获推荐 中天科技目标价涨幅超65%丨券商评级观察
Group 1 - The core viewpoint of the article highlights the significant target price increases for certain listed companies from November 24 to November 30, with notable gains in the telecommunications, motorcycle, and special steel industries [1][2]. Group 2 - The companies with the highest target price increases include: - Zhongtian Technology with a target price increase of 66.77% to 26.40 CNY, rated as "Buy" by Guotai Junan Securities [3]. - Aima Technology with a target price increase of 55.79% to 48.00 CNY, rated as "Outperform" by CITIC Securities [3]. - Xianglou New Materials with a target price increase of 50.25% to 90.00 CNY, rated as "Hold" by CITIC Securities [3]. Group 3 - A total of 238 listed companies received broker recommendations during the same period, with notable mentions including: - GAC Group, Meihua Biological, and Fangsheng Pharmaceutical, each receiving recommendations from two brokers [4][5]. Group 4 - There were 53 instances of first-time coverage by brokers, with key companies such as: - Zhongli Co., Ltd. receiving a "Buy" rating from Dongwu Securities [6]. - Hars receiving an "Outperform" rating from Guosen Securities [6]. - GAC Group and Zhonghang Gaoke also received "Buy" ratings from Guotai Junan Securities [6].
摩托车及其他板块11月28日涨1.62%,征和工业领涨,主力资金净流入2046.08万元
从资金流向上来看,当日摩托车及其他板块主力资金净流入2046.08万元,游资资金净流入120.65万元, 散户资金净流出2166.72万元。摩托车及其他板块个股资金流向见下表: | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 003033 | 征和工业 | 66.66 | 6.98% | 3.18万 | 2.07亿 | | 601777 | 千里科技 | 10.72 | 3.88% | 30.51万 | 3.21亿 | | 603787 | 新日股份 | 14.17 | 1.72% | 2.88万 | 4041.29万 | | 603129 | 春风动力 | 264.50 | 1.62% | 1.34万 | 3.50亿 | | 6600099 | 林海股份 | 10.86 | 1.50% | 2.87万 | 3070.65万 | | 600818 | 中路股份 | 10.64 | 1.14% | 4.32万 | 4557.22万 | | 603529 | 爱玛科技 | 30.81 | 1.08% ...
35股获推荐,爱玛科技目标价涨幅超50%
Group 1 - The core viewpoint of the article highlights the target price increases for several listed companies as of November 27, with notable gains for Aima Technology, Haier Biomedical, and Yaxiang Integration, showing increases of 57.48%, 36.35%, and 34.58% respectively [1][2] - A total of 13 target price adjustments were made by brokerages, with Aima Technology receiving the highest target price increase [1][2] - On November 27, 35 listed companies received brokerage recommendations, with companies like Zhongmu Co., West Securities, and GAC Group receiving one recommendation each [2] Group 2 - On the same date, 11 companies received initial coverage from brokerages, including GAC Group, which was rated "Buy" by Guotai Junan Securities [3][4] - Other companies receiving initial coverage include Haixi Communications, Yutong Technology, and Iwu Biological, all rated "Buy" or "Increase" by various brokerages [3][4] - The industries represented among the newly covered companies include passenger vehicles, automation equipment, packaging printing, and biological products [4]